Samuel Agresta
Equibles does not estimate personal net worth.
About Samuel Agresta
The proxy statement of Foghorn Therapeutics Inc. reports total compensation of $1,809,604 for Samuel Agresta in fiscal 2021, including a base salary of $428,500. Disclosed compensation is on record for 3 fiscal years.
Affiliation history
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $428,500 | $1,809,604 |
| 2020 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $412,000 | $1,053,797 |
| 2019 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $116,667 | $1,202,274 |
Recent activity
No call appearances or filed executive changes recorded yet.